Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance.

@article{Othman2007AdenovirusinducedTT,
  title={Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance.},
  author={Maha Othman and Andrea Labelle and Ian Mazzetti and Hisham S. Elbatarny and David Lillicrap},
  journal={Blood},
  year={2007},
  volume={109 7},
  pages={
          2832-9
        }
}
Thrombocytopenia has been consistently reported following the administration of adenoviral gene transfer vectors. The mechanism underlying this phenomenon is currently unknown. In this study, we have assessed the influence of von Willebrand Factor (VWF) and P-selectin on the clearance of platelets following adenovirus administration. In mice, thrombocytopenia occurs between 5 and 24 hours after adenovirus delivery. The virus activates platelets and induces platelet-leukocyte aggregate formation… 

Figures from this paper

Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia.

The data suggest that Ad5 may induce thrombocytopenia by direct activation of endothelial cells in addition to its direct effects on platelets, and that this simple vector modification may have utility to improve the safety of Ad vectors for human gene therapy.

Adenovirus type 3 induces platelet activation in vitro.

HAdVs may induce activation of platelets and lead to a pre-thrombotic state of peripheral blood and may aid in the development of measures to prevent severe HAdV infection.

Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration

It is shown that intravenous but not intramuscular injection of ChAdOx1 nCov-19 triggers platelet-adenovirus aggregate formation and platelet activation, which contributes to the understanding of TTS and highlights accidental intravenous injection as potential mechanism for post-vaccination TTS.

Proposed mechanism for thrombotic thrombocytopenia induced by adenovirus-based COVID-19 vaccines

It is proposed that VITT arises when the adenovirus vectors come into contact with blood (e.g. when the syringe ruptures a blood vessel), and a B cell with week affinity for PF4 binds to and phagocytoses platelets to which high amounts of inocculated virus stick.

The infection of microvascular endothelial cells with ExoU-producing Pseudomonas aeruginosa triggers the release of von Willebrand factor and platelet adhesion.

Flow cytometry and confocal microscopy showed that increased amounts of vWF were associated with cytoplasmic membranes from cells infected with the ExoU-producing bacteria, likely to modify the thromboresistance of microvascular endothelial cells.

Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)

Initial observations indicating that VITT-like antibodies might also be present in rare patients with recurrent venous and arterial thrombotic complications, independent of vaccination are summarized.

Platelet–adenovirus vs. inert particles interaction: Effect on aggregation and the role of platelet membrane receptors

It is demonstrated that platelets react differentially with foreign particles and that αIIbβ3 is a key player in platelet engulfing of foreign particles but not in mediating adenovirus internalization.

Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis.

A new link between platelets and their response to single-stranded RNA viruses that involves activation of TLR7 is identified, and platelet-TLR7 stimulation is independent of thrombosis and has implications to the host immune response and survival.

Pathogenic Mechanisms of Vaccine-Induced Immune Thrombotic Thrombocytopenia in People Receiving Anti-COVID-19 Adenoviral-Based Vaccines: A Proposal

A multistep mechanism involving both the AVV and the neo-synthetized Spike protein, which may trigger aberrant inflammatory and immune responses in people affected by the mast cell activation syndrome (MCAS), is proposed.

Equid Herpesvirus Type 1 Activates Platelets

The results indicate that EHV-1 activates equine platelets and that α-granule secretion is a consequence of virus-associated tissue factor triggering factor X activation and thrombin generation, and provides a new mechanism by which viruses activate hemostasis.
...

References

SHOWING 1-10 OF 56 REFERENCES

Adenoviral vectors do not induce, inhibit, or potentiate human platelet aggregation.

The results suggest that the adenovirus-associated thrombocytopenia observed in vivo is independent of a direct effect of the virus on platelet aggregation.

P-Selectin and platelet clearance.

It is shown that P-selectin, despite its binding to leukocytes, does not mediate platelet clearance, however, the generation of a soluble form of P- selectin on platelet activation may have biological implications in modulating leukocyte recruitment or thrombus growth.

Thrombopoietin induces p-selectin expression on platelets and subsequent platelet/leukocyte interactions.

This is the first report that identifies TPO as a promoter of platelet-leukocyte interactions in whole blood through expression of Platelet P-selectin.

Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin.

It is concluded that the presence of activated platelets in circulation promotes acute inflammation by stimulating secretion of Weibel-Palade bodies and P-selectin-mediated leukocyte rolling.

P-Selectin Glycoprotein Ligand 1 (Psgl-1) Is Expressed on Platelets and Can Mediate Platelet–Endothelial Interactions in Vivo

It is indicated that functional PSGL-1 is expressed on platelets, and this work suggests an additional mechanism by which selectins and their ligands participate in inflammatory and/or hemostatic responses.

Platelet Glycoprotein Ibα Is a Counterreceptor for the Leukocyte Integrin Mac-1 (Cd11b/Cd18)

The platelet counterreceptor is identified as glycoprotein (GP) Ibα, a component of the GP Ib-IX-V complex, the platelet von Willebrand factor (vWf) receptor, which provides a molecular target for disrupting leukocyte–platelet complexes that promote vascular inflammation in thrombosis, atherosclerosis, and angioplasty-related restenosis.

Pro-coagulant state resulting from high levels of soluble P-selectin in blood.

It is proposed that sP-sel should no longer be considered only as a marker of inflammation or platelet activation, but also as a direct inducer of pro-coagulant activity associated with vascular and thrombotic diseases.

Chlamydia pneumoniae Binds to Platelets and Triggers P-Selectin Expression and Aggregation: A Causal Role in Cardiovascular Disease?

The findings demonstrate a new concept of how C pneumoniae activates platelets and thereby may cause atherosclerosis and thrombotic vascular occlusion.

The P‐selectin, tissue factor, coagulation triad

The roles of P‐sel and TF‐positive MPs are discussed and strategies to modulate hemostasis by modulating the P‐sels, TF, coagulation triad are highlighted.

Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo.

The results suggest that platelets express various TLRs and that the functional significance of one of these, TLR4, appears to be a role in the modulation of LPS-induced thrombocytopenia and TNF-alpha production, and implicates platelets as important mediators of innate immune responses against invading microorganisms.
...